Three familial cases of drug-resistant Mycoplasma pneumoniae infection

European Journal of Pediatrics

Volumn 169, Issue 6, 2010, Pages 721-726

  Kamizono, Shintaro ^a   Ohya, Hitomi ^b   Higuchi, Sadanobu ^a   Okazaki, Norio ^b   Narita, Mitsuo ^c  

^a Kamiamakusa General Hospital   (Japan)

^b KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c Sapporo General Hospital of Hokkaido Railway Company   (Japan)

Author keywords

Age; Drug resistance; Intrafamilial infection; Mycoplasma pneumoniae; Severity

Indexed keywords

ADENINE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GUANINE; JOSAMYCIN; MINOCYCLINE; OLEANDOMYCIN; RNA 23S; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; TETRACYCLINE; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CHILD; CLINICAL FEATURE; CULTURE MEDIUM; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; LABORATORY TEST; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMMUNITY, INNATE; JAPAN; MALE; PNEUMONIA, MYCOPLASMA; SIBLINGS;

EID: 77952095609     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-009-1100-3     Document Type: Article

References (29)

1. GW Amsden 2005 Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 55 10 21 10.1093/jac/dkh519 10.1093/jac/dkh519 1:CAS:528: DC%2BD2MXkt1aisg%3D%3D 15590715 (Pubitemid 40192609)
2. CM Bébéar S Pereyre 2005 Mechanisms of drug resistance in Mycoplasma pneumoniae Curr Drug Targets-Infect Dis 5 263 271 10.2174/1568005054880109 (Pubitemid 41448372)
3. M-W Chan K-H Kim I Park 2004 Mutations of erythromycin-resistant isolates of Mycoplasma pneumoniae in Korea Japanese Journal of Mycoplasmology 31 88 89
4. IA Critchley ME Jones PD Heinze, et al. 2002 In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe Clin Microbiol Infect 8 214 221 10.1046/j.1469-0691.2002.00392.x 10.1046/j.1469-0691.2002.00392.x 1:CAS:528:DC%2BD38XkvVymsbg%3D 12047413 (Pubitemid 34993788)
5. Dumke R, von Baum H, Lück PC, Jacobs E. (2009) Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect (in press)
6. M Ieven D Ursi H Van Bever, et al. 1996 Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of Mycoplasma pneumoniae in acute respiratory tract infections in pediatric patients J Infect Dis 173 1445 1452 1:STN:280:DyaK283hslOnsQ%3D%3D 8648218
7. Y Liu X Ye H Zhang PC Hu 2009 Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis on macrolide-resistant strains from Shanghai Antimicrob Agents Chemother 53 2160 2162 10.1128/AAC.01684-08 10.1128/AAC.01684-08 1:CAS:528:DC%2BD1MXlvVGnsrY%3D 19273684
8. TS Lucier K Heitzman S-K Liu, et al. 1995 Transition mutations in the 23S rRNA of erythromycin- resistant isolates of Mycoplasma pneumoniae Antimicrob Agents Chemother 39 2770 2773 1:CAS:528:DyaK2MXps1Orsbc%3D 8593017
9. M Matsuoka M Narita N Okazaki, et al. 2004 Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan Antimicrob Agents Chemother 48 4624 4630 10.1128/AAC.48.12. 4624-4630 10.1128/AAC.48.12.4624-4630.2004 1:CAS:528:DC%2BD2cXhtVKmtrbJ 15561835
10. M Morozumi K Hasegawa R Kobayashi, et al. 2005 Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23SrRNA gene mutation Antimicrob Agents Chemother 49 2302 2306 10.1128/AAC.49.6 10.1128/AAC.49.6.2302- 2306.2005 1:CAS:528:DC%2BD2MXkvFCgsr0%3D 15917525
11. M Morozumi S Iwata K Hasegawa, et al. 2008 Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia Antimicrob Agents Chemother 52 348 350 10.1128/AAC.00779-07 10.1128/AAC.00779-07 1:CAS:528:DC%2BD1cXkslemsQ%3D%3D 17954691
12. Y Nagayama N Sakurai K Yamamoto, et al. 1988 Isolation of Mycoplasma pneumoniae from children with lower-respiratory-tract infections J Infect Dis 157 911 917 1:STN:280:DyaL1c7pvFWruw%3D%3D 3129522
13. M Narita H Tanaka S Abe, et al. 2000 Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon Clin Diagn Lab Immunol 7 909 914 1:CAS:528:DC%2BD3MXkt1OjtL0%3D 11063497
14. M Narita H Tanaka S Yamada, et al. 2001 Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection Clin Diagn Lab Immunol 8 1028 1030 10.1128/CDLI.8.5 1:CAS:528: DC%2BD3MXnt1Sks74%3D 11527824
15. Y Niitu S Hasegawa H Kubota 1974 In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae Antimicrob Agents Chemother 5 513 519 1:CAS:528:DyaE2cXkslaqsbw%3D
16. Y Niitu S Hasegawa T Suetake, et al. 1970 Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics J Pediatr 76 438 443 10.1016/S0022-3476(70)80485-1 1:STN:280:DyaE3c7gslaitw%3D%3D 5413664
17. N Okazaki M Narita S Yamada, et al. 2001 Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro Microbiol Immunol 45 617 620 1:CAS:528:DC%2BD3MXmvFWgtL8%3D 11592636
18. N Okazaki H Ohya T Sasaki 2007 Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa prefecture in 1976-2006: emergence of macrolide-resistant strains Jpn J Infect Dis 60 325 326 17881881
19. S Pereyre A Charron H Renaudin, et al. 2007 First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years J Clin Microbiol 45 3534 3539 10.1128/JCM.01345-07 10.1128/JCM.01345-07 1:CAS:528:DC%2BD2sXhsVWrtLrO 17881549 (Pubitemid 350156844)
20. O Peuchant A Menard H Renaudin, et al. 2009 Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis J Antimicrob Chemother 64 52 58 10.1093/jac/dkp160 10.1093/jac/dkp160 1:CAS:528:DC%2BD1MXntlGgsL8%3D 19429926
21. N Sakurai Y Nagayama A Honda, et al. 1988 Mycoplasma pneumoniae and other pathogens in the aetiology of lower respiratory tract infections among Japanese children J Infect 16 253 261 10.1016/S0163-4453(88)97604-9 1:STN:280: DyaL1c3osFyiug%3D%3D 2840466
22. CM Salvatore C Techasaensiri C Tagliabue, et al. 2009 Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia Antimicrob Agents Chemother 53 1546 1551 10.1128/AAC.00979-08 10.1128/AAC.00979-08 1:CAS:528:DC%2BD1MXksFWksbo%3D 19139287
23. T Stopler D Branski 1986 Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B J Antimicrob Chemother 18 359 364 10.1093/jac/18.3.359 1:CAS:528:DyaL28XlvVOntLY%3D 3095300
24. S Suzuki T Yamazaki M Narita, et al. 2006 Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae Antimicrob Agents Chemother 50 709 712 10.1128/AAC.50.2 10.1128/AAC.50.2.709-712.2006 1:CAS:528:DC%2BD28XhsFegur0%3D 16436730
25. H Tanaka M Narita S Teramoto, et al. 2002 Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults Chest 121 1493 1497 10.1378/chest.121.5.1493 10.1378/chest.121.5.1493 1:CAS:528:DC%2BD38XksFGgtL8%3D 12006434 (Pubitemid 34499661)
26. KB Waites DF Talkington 2004 Mycoplasma pneumoniae and its role as a human pathogen Clin Microbiol Rev 17 697 728 10.1128/CMR.17.4 10.1128/CMR.17.4.697-728.2004 1:CAS:528:DC%2BD2cXhtVSht7jK 15489344
27. BJ Wolff WL Thacker SB Schwartz JM Winchell 2008 Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis Antimicrob Agents Chemother 52 3542 3549 10.1128/AAC.00582-08 10.1128/AAC.00582-08 1:CAS:528:DC%2BD1cXht1SrtbnM 18644962
28. D Xin Z Mi X Han, et al. 2009 Molecular mechanism of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China Antimicrob Agents Chemother 53 2158 2159 10.1128/AAC.01563-08 10.1128/AAC.01563-08 1:CAS:528:DC%2BD1MXlvVGnsrk%3D 19273685
29. J Yang WC Hooper DJ Phillips DF Talkington 2004 Cytokines in Mycoplasma pneumoniae infections Cytokine Growth Fac Rev 15 157 168 10.1016/j.cytogfr.2004. 01.001 10.1016/j.cytogfr.2004.01.001 1:CAS:528:DC%2BD2cXjsVWmsr8%3D (Pubitemid 38521251)